Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. SPY
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results

Galmed Pharma (GLMD) Tops Q1 EPS by 66c

May 14, 2020 7:05 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of $0.29, $0.66 better than the analyst estimate of ($0.37).

"Over the last few years, Galmed has been in the process of developing a new product, Aramchol meglumine, which is a salt form of Aramchol free acid. It... More